English
banner1
BANNER1
BANNER2
BANNER3-1

About our company

What do we do?

Jiangxi ZhuoRuiHua Meidical instruments Co., Ltd. is mainly engaged in the R&D, manufacturing and sales of endoscopic diagnostic instruments and consumables. We’re committed to providing superior quality, affordable and durable products to hospitals and clinics within the reach of healthcare professionals worldwide.

view more

Hot products

Our products

MISSION

ZRH med are committed to continuous product improvement and refinement to provide users with high-quality products and services.

INQUIRY NOW
  • Competitive price gains you greater profit margin

    Affordable

    Competitive price gains you greater profit margin

  • Strict quality control to ensure the good quality of our products which gains you good reputation as well as trust from your end clients.

    Safety Assurance

    Strict quality control to ensure the good quality of our products which gains you good reputation as well as trust from your end clients.

  • Professional R&D team and continuous investment to complete the product chain which gains you more chance in the market.

    Expertise

    Professional R&D team and continuous investment to complete the product chain which gains you more chance in the market.

Latest information

news

news_img
This article analyzes SonoScape Medical’s annual reports from 2021 to 2026, including its 2026 semi-annual report. SonoScape released its semi-annual report on August 21st. I believe that reviewing the data over a longer period provides a more comprehensive and objective picture, allow...

From 1.4 Billion to 2.3 Billion: An Analysis of SonoScape Medical’s Annual Reports – What Has It Experienced Over the Years?

This article analyzes SonoScape Medical’s annual reports from 2021 to 2026, including its 2026 semi-annual report. SonoScape released its semi-annual report on August 21st. I believe that reviewing the data over a longer period provides a more comprehensive and objective picture, allow...

Aohua Endoscopy H1 Report: Behind Revenue Growth, Widening Losses with Explanations

Key Takeaway Upfront: Revenue rose by 7.37%, yet losses more than doubled compared with the same period last year. This seemingly contradictory set of figures becomes clear upon breakdown — the core business remains sound, while three major headwinds weighed on performance simultaneously, as e...
Hit enter to search or ESC to close